All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Radiopharmaceuticals
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, June 10, 2023
Home » Topics » Financings

Financings
Financings RSS Feed RSS

Hookipa seeks $50M as it prepares to progress HPV cancer drug to phase III

June 1, 2023
By Caroline Richards
No Comments
Hookipa Pharma Inc. is looking to raise about $50 million in a public offering to further advance its lead immunotherapy candidate, HB-200, into a pivotal phase III trial in combination with Keytruda (pembrolizumab, Merck & Co. Inc.) for the first-line treatment of recurrent or metastatic head and neck cancer associated with human papillomavirus (HPV) 16.
Read More

Financings for June 1, 2023

June 1, 2023
No Comments
Biopharmas raising money in public or private financings, including: Effector, Lexicon, Lyra, Oculis, Phion, Pneumagen.
Read More

Financings for May 31, 2023

May 31, 2023
No Comments
Med-tech firms raising money in public or private financings, including: Boston Scientific.
Read More

Financings for May 31, 2023

May 31, 2023
No Comments
Biopharmas raising money in public or private financings, including: Anocca, Belite, Cybin, Lynk, Phio, Violet.
Read More

Financings for May 30, 2023

May 30, 2023
No Comments
Med-tech firms raising money in public or private financings, including: Encare, Revamp Medical.
Read More

Heartseed raises ¥2B to continue trials of iPSC-derived cardiomyocytes for heart failure

May 30, 2023
By Tamra Sami
No Comments
Heartseed Inc. raised ¥2 billion (US$14.3 million) in a series D round to continue the phase I/II Lapis trial of its allogeneic induced pluripotent stem cell (iPSC)-derived cardiomyocytes for heart failure. The lead asset, HS-001, is an investigational cell therapy consisting of clusters of purified heart muscle cells (cardiomyocyte spheroids) derived from iPSCs that are designed to restore heart muscle and function in patients with advanced heart failure.
Read More

Financings for May 30, 2023

May 30, 2023
No Comments
Biopharmas raising money in public or private financings, including: Alpha Cognition, Biodexa, Defence, Dermata, Mydecine, Oculis, Rakovina.
Read More
tissium.jpg

Tissium raises $54M for launch of programmable products for tissue reconstruction

May 26, 2023
By Bernard Banga
No Comments
Tissium SA reported the close of a series D funding round, raising $54 million from investors both new – such as Mérieux Développement SAS – and long-term, including Cathay Capital Co. Ltd., Crédit Mutuel Innovation SAS and original investors, Sofinnova Partners SAS.
Read More

Heartseed raises ¥2B to continue trials of iPSC-derived cardiomyocytes for heart failure

May 26, 2023
By Tamra Sami
No Comments
Heartseed Inc. raised ¥2 billion (US$14.3 million) in a series D round to continue the phase I/II Lapis trial of its allogeneic induced pluripotent stem cell (iPSC)-derived cardiomyocytes for heart failure. The lead asset, HS-001, is an investigational cell therapy consisting of clusters of purified heart muscle cells (cardiomyocyte spheroids) derived from iPSCs that are designed to restore heart muscle and function in patients with advanced heart failure.
Read More

Financings for May 26, 2023

May 26, 2023
No Comments
Biopharmas raising money in public or private financings, including: Agile, Aptose, Carmot, Effector, Lyra, Tscan, Vivoryon.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 394 395 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 9, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 9, 2023.
  • Medical cannabis in blister pack of capsules

    Zelira’s stock triples as cannabinoid outperforms Lyrica in pain

    BioWorld
    Medicinal cannabis company Zelira Therapeutics Ltd.’s stock shot up 224% on May 31 on the heels of news that its cannabinoid product, ZLT-L-007, outperformed...
  • Gavel and First Amendment

    Citing US constitutional violations, Merck the first to challenge the IRA

    BioWorld
    The question wasn’t if, but when and how, someone would challenge the Medicare negotiation provision laid out in the Inflation Reduction Act (IRA) that was signed...
  • Cerebellum, brain stem, spinal cord

    Reprocell reports mixed results for phase II Stemchymal trial in spinocerebellar ataxia

    BioWorld
    Regenerative medicine product Stemchymal, an allogeneic adipose-derived mesenchymal stem cell treatment, missed the primary efficacy endpoints in two phase II...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing